Science Corp. and Neurosoft Bioelectronics Announce Novel BCI Ecosystem Partnership

Deal Joins Science’s World-Class BCI Tools with Neurosoft’s Leading Neural Data Platform ALAMEDA, Calif. & GENEVA–(BUSINESS WIRE)–Science Corporation, the pioneering full-stack neural engineering company focused on restoring and extending life, and Neurosoft Bioelectronics, a neural data company utilizing ultra-soft interfaces to achieve full-cortical coverage powering a foundation AI model of the brain, have partnered to … [Read more…]

Goli Nutrition Launches the “Oscars for Creators” with Inaugural Black-Tie Gala

600 creators will walk the red carpet as social commerce surpasses $100 billion WEST HOLLYWOOD, Calif.–(BUSINESS WIRE)–#ExpoWest–Goli Nutrition Inc., in collaboration with TikTok, will host the inaugural Goli Gala on March 3 in Anaheim, California. The awards ceremony will occur on the opening night of Natural Products Expo West, the largest natural and organic products … [Read more…]

Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026

BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on Monday, March 2, 2026, at 4:30 p.m. E.T., to discuss its fourth quarter and full year 2025 financial results. Quanterix will issue a press release regarding its … [Read more…]

Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference

HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to present at the upcoming 46th Annual TD Cowen Healthcare Conference in Boston. Pulse Biosciences’ Management is scheduled to present on Wednesday, March 4, 2026, at 1:10 pm … [Read more…]

FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia

– First and only all-oral, fixed-duration regimen designed to provide CLL patients with the potential to experience time off treatment – – Approval expands Genentech’s fixed-duration portfolio by providing eligible first-line patients another option alongside the established Venclexta plus Gazyva regimen – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, … [Read more…]

Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D

TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (TSE: 4568) has appointed John Tsai, MD to succeed Ken Takeshita, MD, who is stepping down as Global Head of R&D, effective April 1, 2026. Dr. Tsai will bring more than 25 years of proven leadership and experience driving innovation to further grow the rich Daiichi … [Read more…]

Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026

NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, February 26, 2026 to report financial results … [Read more…]

Animate Biosciences Reports Preclinical Data Showing Dramatic Reduction in Cardiac Scarring and Near-Doubling of Heart Function After Experimental Heart Attack

Single-dose designed peptide drives structural and functional cardiac repair in a mouse myocardial infarction model SAN FRANCISCO–(BUSINESS WIRE)–Animate Biosciences, a biotechnology company focused on designing innovative peptide therapeutics, today announces positive preclinical results demonstrating that its lead therapeutic peptide, MBb32, produced a significant reduction in cardiac scar tissue (infarct) and subsequent recovery of heart function … [Read more…]

United Aesthetics Alliance Announces Partnership With LivSkin MedSpa | Laser

MINNEAPOLIS–(BUSINESS WIRE)–United Aesthetics Alliance (“UAA” or the “Company”), a leading platform of plastic surgery practices and medical spa brands, today announced its partnership with LivSkin MedSpa | Laser (“LivSkin”), a medical spa industry leader in anti-aging products and procedures based in Minneapolis. The transaction represents a significant strategic acquisition that further strengthens UAA’s presence in … [Read more…]

Millennium Systems International Introduces MeevoPay Giving, Enabling Seamless Checkout Donations for Salons, Spas, and Med Spas

PARSIPPANY, N.J.–(BUSINESS WIRE)–Millennium Systems International (MSI), the maker of Meevo, the award-winning salon, spa, and med spa software platform, announced today the launch of MeevoPay Giving, a new capability that allows businesses using MeevoPay to offer guests the option to make a charitable donation to industry nonprofits directly at checkout. MeevoPay Giving was created on … [Read more…]